Back to
NEW YORK LIFE INVESTMENT MANAGEMENT LLC
IMVT
Showing 0 of 8 quarters
Position history for
NEW YORK LIFE INVESTMENT MANAGEMENT LLC's holdings in IMMUNOVANT INC
No. New York Life Investment Management exited its IMVT (Immunovant) position in Q1 2024. Its Q4 2023 13F listed 22,438 shares worth $945,313. New York Life Investment Management first reported IMVT in Q2 2022 and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.